Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 8Unknown 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 2Leukemia 2Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Hodgkin Disease 1Congenital Abnormalities 1

Interventions

Cytarabine 9Daunorubicin 5Peripheral Blood Stem Cell Transplantation 4Idarubicin 4Etoposide 4Radiotherapy 3Mitoxantrone 3Filgrastim 3Cyclophosphamide 3lintuzumab 2Microarray Analysis 2Busulfan 2sargramostim 1midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1aldesleukin 1Tretinoin 1Thioguanine 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Mesna 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1Everolimus 1DNA Methylation 1Clofarabine 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelomonocytic, Acute × Clofarabine × Clear all
NCT00838240 2012-07-20

AML-14A

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Unknown
114 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡